Pay in 4 interest-free payments of $30.00 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
primary melanocytes but no effect on the viability in A375 cells
Chemical Name: 2-(4-chlorophenyl)-3-methyl-1λ⁶
Impact of MET alterations on targeted therapy with EGFR-tyrosine kinase inhibitors for EGFR-mutant lung cancer
NB598 causes a significant decrease in cholesterol by 49±2%
Kornoushenko
BRAF inhibitor - CAS# 918505-61-0 mostat Hydrochloride primary melanocytes but no effectVemurafenib Analog is a potent BRAF inhibitor and the isomer of Vemurafenib. Vemurafenib, also known as PLX4032, RG7204 or RO5185426, is an orally bioavailable, ATP competitive, small molecule inhibitor of BRAF(V600E) kinase with potential antineoplastic activity. Vemurafenib received FDA approval for the treatment of late stage melanoma on August 17, 2011. Product information CAS Number: 918505 61 0 Molecular Weight: 456. 47 Formula: C22H18F2N4O3S
US$ 22.00
US$ 26.00
US$ 20.00
US$ 12.00
US$ 20.00
US$ 44.00
US$ 12.95
US$ 26.00
US$ 28.00
US$ 26.00